Sign in

CIK 0000949858

  • Non-accelerated filer
  • Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Tickers
ACHV QUIT
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
954343413
Phone
+1 425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC

Securities

  • ACHV Common stock Nasdaq
  • QUIT Common Shares Nasdaq
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 4 Grant or award Principal Accounting Officer acquired 2,857 shares (grant or award)
  4. 4 Grant or award President & CMO acquired 2,660 shares (grant or award)
  5. 4 Grant or award CEO acquired 5,000 shares (grant or award)
  6. 4 Shares withheld for taxes Principal Accounting Officer gave up 2,250 shares (to pay taxes)
  7. 4 Shares withheld for taxes President & CMO gave up 3,957 shares (to pay taxes)
  8. 4 Shares withheld for taxes Executive Chairman gave up 10,125 shares (to pay taxes)
  9. 4 Shares withheld for taxes CEO gave up 6,088 shares (to pay taxes)
  10. 4 Open-market buy Executive Chairman bought 10,000 shares at $4.59 ($45,850)
  11. 4 Open-market buy CEO bought 10,000 shares at $4.59 ($45,850)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 4 of 24 · 465 filings